The first experience of gene therapy for the complex treatment of no-option chronic limb-threatening ischemia

<p><strong>Aim.</strong> To evaluate the effects of complex treatments with no-option chronic limb-threatening ischemia patients with ulcers, using plasmid-based vascular endothelial growth factor-165 (VEGF-165) gene therapy in a one year follow-up period.</p><p><str...

Full description

Bibliographic Details
Main Authors: Yu. V. Chervyakov, H. N. Ha
Format: Article
Language:Russian
Published: Meshalkin National Medical Research Center 2020-12-01
Series:Патология кровообращения и кардиохирургия
Subjects:
Online Access:http://journalmeshalkin.ru/index.php/heartjournal/article/view/888